8.74
Fulcrum Therapeutics Inc (FULC) 最新ニュース
Fulcrum Therapeutics Inc. stock outlook for YEARJuly 2025 Breakouts & Capital Protection Trading Alerts - newser.com
How institutional buying supports Fulcrum Therapeutics Inc. stockJuly 2025 Spike Watch & Precise Swing Trade Entry Alerts - newser.com
Is Fulcrum Therapeutics Inc. stock poised for growthTrend Reversal & Low Risk Entry Point Guides - newser.com
How to build a dashboard for Fulcrum Therapeutics Inc. stock2025 Short Interest & Reliable Price Action Trade Plans - newser.com
Fulcrum Therapeutics Inc. stock volume spike explainedJuly 2025 Closing Moves & Free Community Supported Trade Ideas - newser.com
What data driven models say about Fulcrum Therapeutics Inc.’s futureWeekly Stock Analysis & AI Driven Stock Movement Reports - newser.com
What is Leerink Partnrs' Estimate for FULC FY2027 Earnings? - MarketBeat
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Leerink Partnrs Has Negative Outlook of FULC FY2027 Earnings - Defense World
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq - MSN
FULCFulcrum Therapeutics Latest Stock News & Market Updates - Stock Titan
Detecting price anomalies in Fulcrum Therapeutics Inc. with AIIPO Watch & Low Drawdown Investment Strategies - newser.com
What moving averages say about Fulcrum Therapeutics Inc.Portfolio Profit Report & Growth Oriented Trade Recommendations - newser.com
Order flow analysis tools used on Fulcrum Therapeutics Inc.2025 Short Interest & Daily Profit Focused Screening - newser.com
Can Fulcrum Therapeutics Inc. recover in the next quarterProduct Launch & High Return Stock Watch Alerts - newser.com
Fulcrum Therapeutics Inc. stock momentum explainedQuarterly Profit Report & Fast Gain Swing Trade Alerts - newser.com
Fulcrum Therapeutics (NASDAQ:FULC) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
Fulcrum Therapeutics (NASDAQ:FULC) Reaches New 12-Month HighHere's What Happened - MarketBeat
Fulcrum Therapeutics, Inc. $FULC Shares Sold by Matisse Capital - MarketBeat
How supply chain issues affect Fulcrum Therapeutics Inc. stockJuly 2025 Chart Watch & Advanced Swing Trade Entry Alerts - newser.com
What does recent volatility data suggest for Fulcrum Therapeutics Inc.July 2025 Trends & Community Consensus Picks - newser.com
Technical analysis overview for Fulcrum Therapeutics Inc. stockTrade Ideas & Growth Focused Entry Reports - newser.com
Published on: 2025-10-05 20:19:33 - newser.com
Pattern recognition hints at Fulcrum Therapeutics Inc. upsideJuly 2025 Fed Impact & Stock Portfolio Risk Management - newser.com
Is Fulcrum Therapeutics Inc. stock trading near support levelsRate Cut & Safe Capital Growth Stock Tips - newser.com
Using flow based indicators on Fulcrum Therapeutics Inc.Trade Entry Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Fulcrum Therapeutics Inc. recovery potential after sell offInflation Watch & Safe Entry Point Identification - newser.com
What earnings revisions data tells us about Fulcrum Therapeutics Inc.Weekly Stock Report & Fast Moving Stock Watchlists - newser.com
Can Fulcrum Therapeutics Inc. stock sustain market leadershipJuly 2025 Fed Impact & Safe Swing Trade Setup Alerts - newser.com
Fulcrum Therapeutics (NASDAQ:FULC) Sets New 52-Week HighTime to Buy? - MarketBeat
Oppenheimer reiterates Outperform on Fulcrum Therapeutics stock ahead of data - Investing.com Canada
What analysts say about Fulcrum Therapeutics Inc stockSwing Trading Watchlist & Set Your Capital Stop-Loss Limits Effectively - earlytimes.in
Fulcrum Therapeutics, MyoKardia end agreement on cardiomyopathy treatments - MSN
大文字化:
|
ボリューム (24 時間):